Introduction
Herbal medicine has gained much popularity in recent years and there is a general belief of safety toward them. The side effects and adverse reactions of those agents are not well described or studied. Many herbs are not what they claim to be and often contain ingredients not listed on the label. Herbal medications consumption may be dangerous and cause problems in different organs by different mechanisms (1) . Star fruit (Averrhoa carambola L.) are known to create oxalate nephrotoxicity, Thunder God Vine (Tripterygium wilfordii Hook) and some traditional African medicines such as Securida longipedunculata, Euphoria matabelensis, Callilepis laureola (Cape aloes) are potent renal tubular toxins. Cranberry juice and Roughbark (Guaicum officinale L.) increase the risk of kidney stones. Ephedra sinica Stapf and Devil's Claw (Harpagophytum procumbens DC. Ex Meisn.) contain ephedrine and can raise the blood pressure dramatically (1) (2) (3) . Tribulus terrestris that is considered as a lithotripsic and renal protective herb has been reported as a nephrotoxic (4) . Acute allergic interstitial nephritis has been reported after the intake of Peruvian Cat's claw (Uncaria tomentosa) (5) . Aristolochic acid from Aristolochia species is the responsible agent for chronic interstitial nephritis, Balkan nephropathy and urothelial carcinoma (5) . Herbal poisoning may be due to their heavy metals or microbial or fungal toxin contamination. It is possible that herbal therapy may be an underreported cause of end-stage renal disease (ESRD) in different regions worldwide (6) (7) (8) .
Case Presentation
A 62-year-old woman with no significant past medical history except type II diabetes mellitus under the treatment of metformin, which was in her usual state of health till one week prior to her admission to the hospital. Initially, her symptoms started with general weakness. Fatigue and shortness of breath were her chief complaints. After admission in a local hospital renal failure was detected. They assumed the renal failure would be an acute process, while she has not any previous history of kidney disease. Despite parenteral fluid and supportive therapy, her general condition deteriorated. Patient then transferred to our hospital when she became oliguric. On admission, she was alert and oriented. However, she was irritable. Blood pressure (BP) was 119/79 mm Hg, pulse rate 106/min, respiratory rate 26/min and her temperature was 38°C. Physical examination revealed icteric sclera with pale conjunctiva. A cardiac examination showed tachycardia with no murmur. Her lungs had inspiratory crackles over both basal lung fields. No organomegaly, skin rashes or lower leg edema detected. Laboratory data showed the following values; white blood cells of 8000/µL. Plasma hemoglobin = 8.6 g/dL, platelets counts = 104 000/µL, serum creatinine=4.3 mg/dL, blood urea nitrogen = 51 mg/dL, aspartate aminotransferase (AST) = 79 IU/L (0-40), alanine aminotransferase (ALT) = 63 IU/L (0-40) and blood glucose was 185 mg/dL. Accordingly serum electrolytes Na=138 mEq/L and serum K was 4.8 mEq/L. Urine analysis showed; 2+ protein 2+ blood with 2 to 5 red blood cells, and 5-10 leukocytes high power field. Total bilirubin level was 6.7 mg/dL with direct bilirubin of 2.1 mg/dl, serum alkaline phosphatase level was 183 IU/L (normal, 32 to 92 IU/L). Additionally serologic study for HBV, HCV, and HIV were negative. An arterial blood gas analysis showed a pH of 7.30 with bicarbonate of 14.4 mmol/L. A lactate dehydrogenase level of 1920 IU/L, with a creatine kinase (CPK) level of 237 U/L was found. Finally prothrombin time and active partial thrombin time were normal. She was admitted with the presumed diagnosis of hemolytic-uremic syndrome. Further work up showed positive indirect antiglobulin (indirect coombs) test. No schistocyte was noted in her peripheral blood smear. The antinuclear antibody (ANA) was negative. The patient underwent renal biopsy and was placed on intravenous methylprednisolone (500 mg/daily) for three consecutive days. Subsequently, her urine output, general condition, renal, liver and anemia panels started to improve. Her serum creatinine decreased from 4.3 to 1.7 mg/dL two weeks after biopsy. A light microscopic study of kidney biopsy revealed renal interstitial edema and infiltration with mononuclear cells and eosinophils that was suggestive of allergic acute interstitial nephritis (AIN) (Figure 1 ). Immunofluorescent studies showed no immune deposits.
Discussion
We reported a diabetic woman who presented with the clinical picture of hemolytic-uremic syndrome. This patient had no history of diarrhea or febrile disease as a trigger for classic hemolytic uremic syndrome (HUS). Lack of thrombocytopenia and schistocyte in peripheral blood smear made thrombotic thrombocytopenic purpura (TTP) unlikely. Finally, negative direct coombs test and no evidence of thrombotic microangiopathic changes in renal biopsy were against presence of atypical or complement mediated HUS (9). The renal biopsy was consistent with AIN which is a relatively uncommon diagnosis in nephrology practice. The exposure to drugs is the main cause of AIN in almost 75% of cases. Systemic disease and infection are other common etiologies for this problem (10) . This patient had no clinical feature in favor of any infection or systemic disease. She also had no changes in her medication list except including to take over-the-counter heat extract fenugreek three weeks prior her admission having a better blood sugar control. Fenugreek is used as an herb, spice and vegetable in cooking for centuries. It has been proposed as a glucose modulating treatment in patients with diabetes mellitus (11) . Clinical presentations of drug induced AIN are often similar. Patients may present with proteinuria, hematuria, fever, rash, flank pain, oliguria, arthralgia, eosinophilia and a sudden onset of worsening of renal function. The renal failure is the only constant clinical manifestation in AIN and usually manifest within three weeks of starting offending agent. The renal replacement therapy may be necessary in half of patients with renal failure (12) . Renal biopsy still is an essential tool to confirm the diagnosis of AIN as eosinophiluria is a low sensitive test (13, 14) . Patchy infiltration of mononuclear cells, predominantly eosinophil around the tubules with normal glomeruli and vessels were more in favor of allergic AIN in this case. In the literature reviews, we found nine reported cases of flavonoid-induced nephropathy who presented with AIN accompanied by autoimmune hemolytic anemia (AIHA) very similar to our case. The mechanism of flavonoid nephropathy is unknown however, an immune-mediated mechanism is highly possible (15, 16) . Flavonoids are found ubiquitously in many herbs, including fenugreek and their antioxidant activities and its cytoprotective effect has frequently been praised in different studies (17, 18) . We speculated that exposure to high flavonoid content A B of fenugreek dried extract might be a culprit for AIN and hemolytic anemia in our patient. The most important step in treating AIN is removing the offending agent. Our patient received three days high dose steroid. The role of steroid in AIN is debatable but we have observed dramatic response in this patient's renal function, urine output and overall wellbeing. The lack of interstitial fibrosis, patchy infiltrates without granuloma formation in addition to decreasing creatinine to 1.4 mg/dL in two weeks lends itself toward a good renal prognosis. This is the first report of fenugreek induced allergic AIN accompanied by AIHA. It may prove wise to question each patient who presenting with acute renal dysfunction of unknown origin about using of herbal/over-the-counter medications. Timely recognition and discontinuation of the offending agent appears to provide the utmost therapeutic role at this time.
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